Double Bond Pharmaceutical International AB (publ)

Research Double Bond Pharmaceutical International AB (publ) (DBP-B.ST) on Bullrun: market cap SEK 24.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerDBP-B.ST
ExchangeXSAT
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 24.96M
Financial periodQ2 2026
RevenueSEK 0
Net income-SEK 608.72K

Valuation Snapshot

latest market cap is SEK 24.96M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	SEK 24.96M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Double Bond Pharmaceutical International AB (publ)

Double Bond Pharmaceutical International AB (publ), a pharmaceutical company, engages in the development and commercialization of cancers and infectious diseases. It offers Temodex / SI053, a gel formulation of temozolomide for the local treatment of glioblastoma; SA-033, a novel treatment of cancers in liver; and SA-083 for the treatment of lung tumour. The company is also developing Belopenem for the treatment of bacterial pneumonia;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Abera Bioscience AB (ABERA.ST) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU) Active Biotech AB (ACTI) AlzeCure Pharma (ALZCUR) Alzinova (ALZ.ST) Annexin Pharmaceuticals (ANNX.ST) Aptahem AB (publ) (APTA.ST) Alligator Bioscience AB (ATORX) BioInvent International (BINV.ST) BioArctic AB (publ) (BIOA-B) Biosergen AS (BIOSGN)

Frequently asked questions

What is Double Bond Pharmaceutical International AB (publ)'s market cap?

Double Bond Pharmaceutical International AB (publ)'s market capitalization is SEK 24.96M.